Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Calluna Pharma has completed a Phase I clinical study of CAL101, a monoclonal antibody targeting S100A4, for fibrotic and fibro-inflammatory diseases.
Calluna Pharma's CAL101, a first-in-class monoclonal antibody, has completed a Phase 1 trial showing a favorable safety, pharmacokinetic, and immunogenicity profile.
Calluna Pharma has appointed Mark Gaffney as Chief Executive Officer to lead the company's strategic initiatives and advance its pipeline.